アフターアワーズ： 52.28

Keros Therapeutics Inc (KROS)

Keros Therapeutics Inc (KROS) 最新ニュース

Keros Therapeutics Inc (KROS)

Keros Therapeutics Inc (KROS) 最新ニュース

William Blair analysts initates an Outperform rating for Keros Therapeutics Inc (KROS) – Knox Daily - Knox Daily

(KROS) Trading Signals - Stock Traders Daily

Keros Therapeutics to Present at the 29th Annual Congress of the European Hematology Association - Yahoo Canada Finance

Keros Therapeutics, Inc. (KROS) Upgraded to Buy: Here's What You Should Know - Yahoo Canada Shine On

Keros Therapeutics, Inc. Expected to Post Q2 2024 Earnings of ($1.20) Per Share (NASDAQ:KROS) - MarketBeat

Keros Therapeutics (NASDAQ:KROS) Stock Rating Reaffirmed by HC Wainwright - Defense World

Russell Investments Group Ltd. Buys 18,682 Shares of Keros Therapeutics, Inc. (NASDAQ:KROS) - MarketBeat

Russell Investments Group Ltd. Acquires 18682 Shares of Keros Therapeutics, Inc. (NASDAQ:KROS) - Defense World

Keros Therapeutics Reports Widening Losses in Q1 2024, Despite Progress in Clinical Trials - Yahoo Finance

Keros Therapeutics (NASDAQ:KROS) Issues Earnings Results, Beats Estimates By $0.12 EPS - MarketBeat

Is a Surprise Coming for Keros Therapeutics (KROS) This Earnings Season? - Yahoo Singapore News

Keros Therapeutics' (KROS) "Buy" Rating Reaffirmed at HC Wainwright - MarketBeat

Keros Therapeutics (NASDAQ:KROS) Issues Earnings Results, Beats Estimates By $0.12 EPS - MarketBeat

Keros Therapeutics Seeks Fast Track FDA Nod for Novel Treatments Amidst Regulatory Uncertainty - TipRanks.com - TipRanks

Recent Insider Activity Suggests Potential Gains for Keros Therapeutics Inc (KROS) – Knox Daily - Knox Daily

Keros Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results - Yahoo Finance

Keros Therapeutics, Inc. (NASDAQ:KROS) Receives Average Rating of "Buy" from Analysts - MarketBeat

(KROS) Long Term Investment Analysis - Stock Traders Daily

Keros Therapeutics (NASDAQ:KROS) Trading Up 7.5% - MarketBeat

Keros Therapeutics Updates Corporate Presentation Online - TipRanks.com - TipRanks

Keros Therapeutics Updates Corporate Presentation Online - TipRanks.com - TipRanks

Keros Therapeutics to Present at Leerink Partners 2024 Global Biopharma Conference

Keros Therapeutics to Present at Leerink Partners 2024 Global Biopharma Conference - GlobeNewswire

Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

Keros Therapeutics, Inc. (KROS) is on the Move, Here's Why the Trend Could be Sustainable

Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results - Yahoo Finance

Does Keros Therapeutics, Inc. (KROS) Have the Potential to Rally 35.66% as Wall Street Analysts Expect?

Does Keros Therapeutics, Inc. (KROS) Have the Potential to Rally 35.66% as Wall Street Analysts Expect? - Yahoo Finance

Recent Price Trend in Keros Therapeutics, Inc. (KROS) is Your Friend, Here's Why

Wall Street Analysts Predict a 45.35% Upside in Keros Therapeutics, Inc. (KROS): Here's What You Should Know

Keros Therapeutics, Inc. (KROS) Is a Great Choice for 'Trend' Investors, Here's Why

Keros Therapeutics Announces Closing of Upsized Public Offering of Common Stock

Keros Therapeutics Announces Closing of Upsized Public Offering of Common Stock - Yahoo Finance

Leerink Partners Serves as Joint Bookrunner for Keros Therapeutics' (Nasdaq: KROS) $140 Million Follow-On Offering - SVB Leerink

Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday

Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher O - Benzinga

Keros Therapeutics Announces Pricing of Upsized Public Offering of Common Stock

Keros Therapeutics Announces Proposed Public Offering of Common Stock

Keros Therapeutics Announces Pricing of Upsized Public Offering of Common Stock - GlobeNewswire

Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session

Coinbase, Riot Platforms, Marathon Digital And Other Big Stocks Moving Lower On Monday

Keros Therapeutics Presents Clinical Data from its KER-050 Program at the 65th American Society of Hematology Annual Meeting and Exposition

Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday’s Mid-Day Session - Af - Benzinga

Keros Therapeutics to Present at Upcoming Healthcare Conferences - Yahoo Finance

Keros Therapeutics to Present at the 65th American Society of Hematology Annual Meeting and Exposition - Yahoo Finance

RKER-065 improves muscle function and prevents bone loss in prednisolone-treated mice - BioWorld Online

Keros Therapeutics Presents Preclinical and Clinical Data from its KER-012 Program at the American Thoracic Society ... - GlobeNewswire

Keros Therapeutics to Present at the 28th Annual Congress of the European Hematology Association - GlobeNewswire

Keros Therapeutics Appoints Alpna Seth, Ph.D., to its Board of Directors - citybiz

KROSに似た銘柄